- Home
- SAVA vs FUSB Comparison
SAVA vs FUSB Comparison
Compare SAVA & FUSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- FUSB
- Stock Information
- Founded
- SAVA 1998
- FUSB 1952
- Country
- SAVA United States
- FUSB United States
- Employees
- SAVA N/A
- FUSB N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- FUSB Major Banks
- Sector
- SAVA Health Care
- FUSB Finance
- Exchange
- SAVA Nasdaq
- FUSB Nasdaq
- Market Cap
- SAVA 70.5M
- FUSB 72.6M
- IPO Year
- SAVA N/A
- FUSB N/A
- Fundamental
- Price
- SAVA $1.88
- FUSB $12.99
- Analyst Decision
- SAVA Buy
- FUSB
- Analyst Count
- SAVA 3
- FUSB 0
- Target Price
- SAVA $54.50
- FUSB N/A
- AVG Volume (30 Days)
- SAVA 1.1M
- FUSB 2.2K
- Earning Date
- SAVA 08-07-2025
- FUSB 07-23-2025
- Dividend Yield
- SAVA N/A
- FUSB 2.17%
- EPS Growth
- SAVA N/A
- FUSB N/A
- EPS
- SAVA N/A
- FUSB 1.28
- Revenue
- SAVA N/A
- FUSB $38,449,000.00
- Revenue This Year
- SAVA N/A
- FUSB N/A
- Revenue Next Year
- SAVA N/A
- FUSB N/A
- P/E Ratio
- SAVA N/A
- FUSB $10.08
- Revenue Growth
- SAVA N/A
- FUSB N/A
- 52 Week Low
- SAVA $1.15
- FUSB $9.10
- 52 Week High
- SAVA $42.20
- FUSB $14.30
- Technical
- Relative Strength Index (RSI)
- SAVA 38.33
- FUSB 46.04
- Support Level
- SAVA $1.75
- FUSB $12.55
- Resistance Level
- SAVA $1.90
- FUSB $13.10
- Average True Range (ATR)
- SAVA 0.10
- FUSB 0.18
- MACD
- SAVA -0.04
- FUSB 0.01
- Stochastic Oscillator
- SAVA 9.30
- FUSB 16.46
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.